Form 8-K - Current report:
SEC Accession No. 0001477932-24-004082
Filing Date
2024-07-05
Accepted
2024-07-05 14:20:47
Documents
17
Period of Report
2024-06-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K avrw_8k.htm   iXBRL 8-K 28760
2 SECURITIES PURCHASE AGREEMENT avrw_ex101.htm EX-10.1 69753
3 FORM OF NOTE avrw_ex102.htm EX-10.2 78567
  Complete submission text file 0001477932-24-004082.txt   329415

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA avrw-20240628.xsd EX-101.SCH 5720
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE avrw-20240628_lab.xml EX-101.LAB 13171
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE avrw-20240628_cal.xml EX-101.CAL 898
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE avrw-20240628_pre.xml EX-101.PRE 8249
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE avrw-20240628_def.xml EX-101.DEF 2099
19 EXTRACTED XBRL INSTANCE DOCUMENT avrw_8k_htm.xml XML 3555
Mailing Address 5805 SEPULVEDA BLVD., SUITE 801 SHERMAN OAKS CA 91411
Business Address 5805 SEPULVEDA BLVD., SUITE 801 SHERMAN OAKS CA 91411 424-273-8675
Avenir Wellness Solutions, Inc. (Filer) CIK: 0001643301 (see all company filings)

EIN.: 371765151 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55908 | Film No.: 241102399
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)